Royal Bank of Canada
TPST icon

Royal Bank of Canada’s Tempest Therapeutics TPST Stock Holding History

Royal Bank of Canada’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
28
+1
+4% +$2 ﹤0.01% 7824
2026
Q1 		$0 Buy
27
+19
+238% +$46 ﹤0.01% 7698
2025
Q4 		$0 Buy
+8
New +$57 ﹤0.01% 7643
2025
Q2 		– Hold
0
– – – 7350
2025
Q1 		– Hold
0
– – – 7233
2024
Q4 		– Hold
0
– – – 7254
2020
Q4 		– Sell
-9
Closed -$3K – 7292
2020
Q3 		$3K Sell
9
-1
-10% -$339 ﹤0.01% 6263
2020
Q2 		$3K Buy
10
+9
+900% +$3.59K ﹤0.01% 6215
2020
Q1 		$0 Sell
1
-3
-75% -$4.38K ﹤0.01% 7024
2019
Q4 		$6K Buy
+4
New +$5.64K ﹤0.01% 6309
2019
Q3 		– Hold
0
– – – 7116
2019
Q2 		– Hold
0
– – – 7183
2019
Q1 		– Hold
0
– – – 7100
2018
Q4 		– Hold
0
– – – 7113
2018
Q1 		– Hold
0
– – – 6785
2017
Q4 		– Hold
0
– – – 6890
2017
Q3 		– Hold
0
– – – 6979
2017
Q2 		– Sell
-1
Closed -$4.23K – 6760
2017
Q1 		$3K Hold
1
– – ﹤0.01% 6364
2016
Q4 		$3K Buy
+1
New +$12.5K ﹤0.01% 6421
2016
Q3 		– Hold
0
– – – 6198
2016
Q1 		– Hold
0
– – – 6647
2015
Q4 		– Hold
0
– – – 6823
2015
Q3 		– Hold
0
– – – 5947
2015
Q2 		– Sell
-1
Closed -$91.6K – 5711
2015
Q1 		$90K Buy
+1
New +$133K ﹤0.01% 4671

Other funds holding TPST

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada's TPST Position: Q2 2026 in Review

Royal Bank of Canada increased its Tempest Therapeutics (TPST) stake by 3.7% in Q2 2026, buying an estimated $2 and bringing the position to 28 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7824.

Royal Bank of Canada first reported a position in TPST in Q1 2015 and has held it in 10 quarters since. The position peaked at $90K in Q1 2015. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

  • Royal Bank of Canada held 28 shares of Tempest Therapeutics worth $0 as of Q2 2026.
  • Royal Bank of Canada bought 1 Tempest Therapeutics share in Q2 2026, an estimated $2.
  • Tempest Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7824 holding.
  • Royal Bank of Canada first reported a position in Tempest Therapeutics in Q1 2015 and has held it in 10 quarters since.
  • Royal Bank of Canada's Tempest Therapeutics position peaked at $90K in Q1 2015.
  • 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.